MarketCap
Facebook
X
TelegramObalon Therapeutics, Inc. Revenue 2011-2026 | OBLN
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Obalon Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 1.59 M | 3.28 M | 9.1 M | 9.91 M | 3.39 M | 4.04 M | 3.54 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.91 M | 1.59 M | 4.98 M |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Medical devices industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
172 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
7.16 M | - | -26.83 % | $ 2.62 M | USA |
 |
Align Technology
ALGN
|
4 B | $ 173.14 | -0.8 % | $ 13 B | USA |
 |
AdaptHealth Corp.
AHCO
|
3.24 B | $ 12.17 | -0.41 % | $ 1.64 B | USA |
 |
Allied Healthcare Products
AHPI
|
6.02 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
764 M | $ 10.9 | -1.54 % | $ 1.64 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
274 M | - | - | $ 3.31 B | USA |
 |
Bio-Rad Laboratories
BIO
|
2.57 B | $ 279.25 | 0.63 % | $ 7.88 B | USA |
 |
BioSig Technologies
BSGM
|
40 K | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
62 M | - | - | $ 16.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
44.1 M | $ 3.3 | -1.79 % | $ 124 M |  France |
 |
Bruker Corporation
BRKR
|
3.37 B | $ 37.59 | -1.03 % | $ 5.6 K | USA |
 |
Boston Scientific Corporation
BSX
|
20.1 B | $ 61.79 | 0.83 % | $ 91.5 B | USA |
 |
Apollo Endosurgery
APEN
|
76.9 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
236 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
37.1 M | $ 0.61 | 0.84 % | $ 38 M | USA |
 |
ClearPoint Neuro
CLPT
|
37 M | $ 8.68 | -3.12 % | $ 246 M | USA |
 |
Dynatronics Corporation
DYNT
|
27.4 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
64 M | $ 24.12 | -1.19 % | $ 204 M | USA |
 |
CryoLife, Inc.
CRY
|
253 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
7.65 M | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
1 K | - | -0.97 % | $ 54.4 M | USA |
 |
Aziyo Biologics
AZYO
|
12.3 M | - | 1.37 % | $ 20.5 M | USA |
 |
Helius Medical Technologies
HSDT
|
644 K | $ 1.89 | - | $ 1.15 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
3.05 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
41 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
62.5 M | - | - | $ 462 M | USA |
 |
Inogen
INGN
|
349 M | $ 6.33 | -4.95 % | $ 168 M | USA |
 |
IRIDEX Corporation
IRIX
|
52.7 M | $ 1.0 | -3.86 % | $ 16.9 M | USA |
 |
Neovasc
NVCN
|
2.55 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
236 M | $ 15.97 | 0.19 % | $ 375 M | USA |
 |
Globus Medical
GMED
|
2.94 B | $ 90.42 | -1.07 % | $ 12.2 B | USA |
 |
LivaNova PLC
LIVN
|
1.39 B | $ 62.78 | -0.93 % | $ 3.42 B |  Britain |
 |
LENSAR
LNSR
|
58.4 M | $ 5.7 | 4.4 % | $ 68.2 M | USA |
 |
Butterfly Network
BFLY
|
82.1 M | $ 4.11 | -0.96 % | $ 870 M | USA |
 |
Intersect ENT, Inc.
XENT
|
80.6 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
49.2 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
85.2 M | $ 10.04 | 1.62 % | $ 360 M | USA |
 |
Inspire Medical Systems
INSP
|
912 M | $ 54.02 | -4.71 % | $ 1.59 B | USA |
 |
CONMED Corporation
CNMD
|
1.37 B | $ 36.74 | -0.51 % | $ 1.14 B | USA |
 |
Myomo
MYO
|
40.9 M | $ 0.69 | -1.43 % | $ 28.9 M | USA |
 |
NanoVibronix
NAOV
|
2.56 M | - | - | $ 1.08 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.85 B | $ 85.11 | -1.8 % | $ 2.96 B | USA |
 |
FONAR Corporation
FONR
|
97.6 M | $ 18.68 | 0.38 % | $ 122 M | USA |
 |
Invacare Corporation
IVC
|
181 M | - | - | $ 24.7 M | USA |